Clinical trials
Phase 2 Leiomyosarcoma trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
5 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 2 |
| 2008 | 1 |
| 2019 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Active, not recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 2 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| NCIC Clinical Trials Group | 1 |
| University Health Network, Toronto | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leiomyosarcoma | 5 |
| Liposarcoma | 4 |
| Histiocytoma, Malignant Fibrous | 3 |
| Sarcoma | 3 |
| Fibrosarcoma | 2 |
| Rhabdomyosarcoma | 2 |
| Sarcoma, Endometrial Stromal | 2 |
| Dermatofibrosarcoma | 1 |
| Endometrial Neoplasms | 1 |
| Hemangiosarcoma | 1 |
Trials
Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.